ISA Pharmaceuticals Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

ISA Pharmaceuticals B.V. is a clinical-stage immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent virus infections. The Company has built a proprietary immunotherapy platform based on its Synthetic Long Peptide (SLP®) concept and its AMPLIVANT® technology. SLP® immunotherapies are designed to fully harness and direct the body’s own defense mechanisms towards fighting the disease, either alone or in combination with existing therap

Company Highlights
Year Founded

2004

icon-altEmployees

10

Location (HQ)

NLD

Since Last Funding

3 years 5 months

icon-altTotal Investment Amt

$63M

Last Funding Round

Series Unknown

icon-altMoM Headcount Growth

-22.9%

icon-altYoY Headcount Growth

-80.23%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology Research

Biotechnology